October 25, 2012

The Food and Drug Administration has declined to approve a drug developed by United Therapeutics Corp. for treating a potentially lethal high blood pressure condition.

October 25, 2012

The leader of pharmacy benefit manager Prime Therapeutics will be the keynote speaker at a specialty pharmacy conference Thursday.

October 23, 2012

Cardinal Health has introduced a new multidose drug packaging system that it said would help pharmacy customers adhere to medication regimens, the company said Tuesday.

October 22, 2012

A deal that would make a specialty pharmacy a distribution source for a new liquid chemotherapy drug may benefit breast cancer patients who have trouble swallowing pills.

October 22, 2012

More patients with an inflammatory disease of the bowels responded to a drug used for autoimmune disorders than those taking a placebo, according to results of a late-stage clinical trial announced Monday.

October 19, 2012

The Food and Drug Administration has given tentative approval to a new drug for HIV made by an Indian company.

October 19, 2012

A division of Wolters Kluwer Health has released a new version of a Web-based quality-assurance software for pharmacy compounding.

October 18, 2012

The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.

October 17, 2012

A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

October 12, 2012

Medical supply company BD has introduced a disposable injection pen that it said was designed for drugs requiring frequent, low-volume injections or variable dosing.

October 12, 2012

The Food and Drug Administration has approved an injected drug for lung cancer made by Celgene, the company said Friday.

October 12, 2012

The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

October 11, 2012

A company that manufactures simplified packaging designed to increase medication adherence has launched a new website to promote the product.

October 11, 2012

A German drug maker is pledging millions of dollars for multiple sclerosis research, the company's U.S. subsidiary said Thursday.

October 9, 2012

Specialty may be the fastest-growing segment, but it may also be the most complicated, as this segment is comprised of very complex medications to treat such serious diseases as cancer, multiple sclerosis and hemophilia.

October 9, 2012

A drug maker and a hospital have entered an agreement aimed at developing new treatments for various types of hematological malignancies and solid tumors.

October 5, 2012

Drug maker Takeda announced that its wholly owned U.S. subsidiary has entered a definitive agreement to acquire LigoCyte Pharmaceuticals, a private clinical-stage biopharmaceutical company focused on developing novel vaccines for gastrointestinal and respiratory indications.

October 4, 2012

The Keystone Folding Box Co. has launched a pharmaceutical compliance packaging system that it said was environmentally sustainable, easy to use for elderly people and resistant to tampering by children.

October 2, 2012

An experimental drug for treating a rare genetic disease appears effective, according to a late-stage clinical trial.

October 2, 2012

Two companies have signed a deal to provide access to real-time medication history to healthcare providers.

October 2, 2012

Walgreens will get a "significant" ownership stake in a specialty pharmacy that treats people with cystic fibrosis under a new deal with the Cystic Fibrosis Foundation, the two announced Tuesday.

October 1, 2012

A pharmacy benefit manager has launched a new specialty pharmacy offering.

September 28, 2012

The Food and Drug Administration has approved a drug made by Abbott for treating ulcerative colitis.

September 28, 2012

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.